nyxoid
mundipharma corporation (ireland) limited - naloxone hydrochloride dihydrate - opioidiin liittyvät häiriöt - kaikki muut terapeuttiset tuotteet - nyxoid on tarkoitettu välittömästi hätätilanteessa hoitoa tunnettujen tai epäiltyjen opioidien yliannostus joka ilmenee hengitysteiden ja/tai keskuksena hermoston masennus kuin lääketieteen ja terveydenhuollon asetukset. nyxoid is indicated in adults and adolescents aged 14 years and over. nyxoid is not a substitute for emergency medical care.
acyrax 200 mg tabletti
orion corporation - aciclovir - tabletti - 200 mg - asikloviiri
acyrax 400 mg tabletti
orion corporation - aciclovir - tabletti - 400 mg - asikloviiri
acyrax 800 mg tabletti
orion corporation - aciclovir - tabletti - 800 mg - asikloviiri
longin sitruuna 3 mg imeskelytabletti
orion corporation - benzydamine hydrochloride - imeskelytabletti - 3 mg - bentsydamiini
corbilta (previously levodopa/carbidopa/entacapone sandoz)
orion corporation - levodopa, karbidopa, entakaponi - parkinsonin tauti - parkinson-lääkkeet - corbilta on tarkoitettu hoito aikuispotilailla, joilla on parkinsonin tauti ja lopulta annoksen motor vaihtelut ole vakaa levodopa/dopa dekarboksylaasin (ddc) estäjä hoitoa.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - systeemiset bakteerilääkkeet, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
zinforo
pfizer ireland pharmaceuticals - keftaroliinifosamiili - community-acquired infections; skin diseases, infectious; pneumonia - systeemiset bakteerilääkkeet, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
nitrosid 1 mg/ml infuusiokonsentraatti, liuosta varten
orion corporation - isosorbidi dinitras - infuusiokonsentraatti, liuosta varten - 1 mg/ml - isosorbididinitraatti
perindopril orion 4 mg tabletti
orion corporation - perindopril tert-butylamine - tabletti - 4 mg - perindopriili